Abstract
Get full access to this article
View all access options for this article.
References
1.Bluebird Bio. bluebird bio provides updated findings from reported case of acute myeloid leukemia (AML) in LentiGlobin for sickle cell disease (SCD) gene therapy program. 2021 . https://investor.bluebirdbio.com/news-releases/news-release-details/bluebird-bio-provides-updated-findings-reported-case-acute (last accessed
March 11 , 2021
).
2.ElevateBio. ElevateBio scales disruptive cell and gene therapy business model with $525 million series C financing. 2021 . https://www.elevate.bio/blogs/elevatebio-scales-disruptive-cell-and-gene-therapy-business-model-with-525-million-series-c-financing (last accessed
March 15 , 2021
).
3.
WuXi AppTec and OX
GENE.
WuXi AppTec completes acquisition of
OXGENE to further strengthen cell and gene therapy service offerings for global customers
. 2021. https://www.oxgene.com/News-and-Events/News/2021/03/WuXi-AppTec-acquire-OXGENE (last accessed
March 11 , 2021
).
4.Caribou Biosciences. Caribou biosciences raises $115M series C financing to advance next-generation CRISPR technologies and allogeneic cell therapy pipeline . https://cariboubio.com/in-the-news/press-releases/caribou-biosciences-raises-115m-series-c-financing-advance-next-generation (last accessed
March 11 , 2021
).
5.Biogen. Biogen announces plans to build a new,
state-of-the-art gene therapy manufacturing facility in Research Triangle
Park
,
North
Carolina
. 2021. https://investors.biogen.com/news-releases/news-release-details/biogen-announces-plans-build-new-state-art-gene-therapy (last accessed
March 11 , 2021
).
6.Catalent and Delphi Genetics. Catalent to acquire delphi genetics and launch US plasmid manufacturing site to establish global pDNA development and manufacturing capabilities. 2021 . https://www.catalent.com/catalent-news/catalent-to-acquire-delphi-genetics-and-launch-us-plasmid-manufacturing-site-to-establish-global-pdna-development-and-manufacturing-capabilities/ (last accessed
March 11 , 2021
).
7.SIRION Biotech. SIRION Biotech announces collaboration with Sanofi to innovate gene therapy treatments with improved adeno-associated virus capsids. 2021 . https://www.businesswire.com/news/home/20210223005260/en/SIRION-Biotech-Announces-Collaboration-with-Sanofi-to-Innovate-Gene-Therapy-Treatments-with-Improved-Adeno-Associated-Virus-Capsids (last accessed
March 11 , 2021
).